Your Location：
Home >
Browse articles >
Mechanism of Wogonin in Alleviating LPS-Induced Inflammation in BV-2 Cells and Protecting SH-SY5Y Cells
Updated：2024-09-12
Previous|Next

    • Mechanism of Wogonin in Alleviating LPS-Induced Inflammation in BV-2 Cells and Protecting SH-SY5Y Cells

    • “The latest research has found that baicalein can regulate the TLR4/MyD88/NF - κ B signaling pathway, inhibit LPS induced release of inflammatory cytokines in BV-2 microglia, protect SH-SY5Y cells, and alleviate inflammation and nerve damage.”
    • SUN Mengfei , OUYANG Jingfeng , WU Chunyang , CHENG Jiaojiao
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 30, Issue 20, Pages: 62-69(2024)

    • DOI： 10.13422/j.cnki.syfjx.20240925     

      CLC：

    Scan QR Code

  •  
  •  

  • AI Introduction

  • Full Text(HTML)

  • Figs( 6 ) Tabs( 5 )

  • References

  • Publication Info

  • Metrics

441

Views

366

Downloads

3

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Chaihu Jia Longgu Muli Tang Inhibits Microglial Activation to Protect Neuro-2A Neurons
Mechanism of Baicalein in Inhibiting Microglial Activation and Protecting SH-SY5Y Nerve Cells
Tongnao Decoction Promotes Angiogenesis and Alleviates Cerebral Ischemic Injury via PI3K/Akt/GSK-3β Signaling Pathway
Tangbikang Granules Improve Diabetic Peripheral Neuropathy by Inhibiting Ferroptosis via AMPK/Nrf2 Signaling Pathway
Key Issues and Research Ideas of Traditional Chinese Medicine Anti-aging Guided by Essence-Qi-spirit Theory of Qiluo Doctrine

Related Author

OUYANG Jingfeng
WU Chuyang
YANG Xinqi
GAO Ruixuan
ZHANG Ziqi
JIA Yongsen
OUYANG Jingfeng
YIN Mengxia

Related Institution

Traditional Chinese Medicine College， North China University of Science and Technology
Experimental Research Center， China Academy of Chinese Medical Sciences
Beijing Key Laboratory of Research of Chinese Medicine on Prevention and Treatment for Major Diseases， Experimental Research Center，China Academy of Chinese Medical Sciences
Dongfang Hospital， Beijing University of Chinese Medicine
Institute of Basic Research in Clinical Medicine， China Academy of Chinese Medical Sciences